Form 8-K - Current report:
SEC Accession No. 0001581280-26-000037
Filing Date
2026-05-04
Accepted
2026-05-04 07:21:04
Documents
13
Period of Report
2026-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K twist-20260504.htm   iXBRL 8-K 30393
2 EX-99.1 twst-2026331xex991.htm EX-99.1 131853
6 image_2a.jpg GRAPHIC 23636
  Complete submission text file 0001581280-26-000037.txt   323711

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT twist-20260504.xsd EX-101.SCH 1825
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT twist-20260504_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT twist-20260504_pre.xml EX-101.PRE 12539
16 EXTRACTED XBRL INSTANCE DOCUMENT twist-20260504_htm.xml XML 2811
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 26934633
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)